Measles Live Attenuated Vaccine麻疹减毒活疫苗

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

人血白蛋白是一种在国家药监局注册认定的药品。该药品含有明胶、经培养、蔗糖-ff4eac60等成分。

该药品关联的活性成分包括:明胶Ming Jiao、经培养Jingpei Yang、蔗糖Zhe Tang。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:北京天坛生物制品股份有限公司Chinese legal name: 北京天坛生物制品股份有限公司。

您可以探索含有相同成分的其他药品:明胶-c141ee52成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 麻疹减毒活疫苗) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 明胶Ming Jiao, 经培养Jingpei Yang, 蔗糖Zhe Tang.

Manufacturers recorded for this product: 北京天坛生物制品股份有限公司Chinese legal name: 北京天坛生物制品股份有限公司.

Explore other medicines containing the same ingredient: 明胶 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 麻疹减毒活疫苗Measles Live Attenuated Vaccine
  • 规格Specification: 复溶后每瓶2.0ml。每1次人用剂量0.5ml,含麻疹活病毒应不低于3.01gCCID50。Recorded Chinese description: 复溶后每瓶2.0ml。每1次人用剂量0.5ml,含麻疹活病毒应不低于3.01gCCID50。

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 北京天坛生物制品股份有限公司Chinese legal name: 北京天坛生物制品股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字S20063038

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字S20063038

Manufacturer

Chinese legal name: 北京天坛生物制品股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字S20063038

生产企业

北京天坛生物制品股份有限公司(国产)

适应症

{接种对象}8个月龄以上的麻疹易感者。全年均适宜接种。|{作用与用途}接种本疫苗后,可刺激机体产生抗麻疹病毒的免疫力。用于预防麻疹。|{免疫程序和剂量}|(1)按每瓶2.0ml加灭菌注射用水,待冻干疫苗完全溶解并摇匀后使用。|(2)于上臂外侧三角肌下缘附着处皮下注射0.5ml。

用法用量

-

不良反应

注射后一般无局部反应。在6~10天内,少数儿童可能出现一过性发热反应以及散在皮疹,一般不超过2天可自行缓解,通常不需特殊处理,必要时可对症治疗。

禁忌

患严重疾病,急性或慢性感染,发热或对鸡蛋有过敏史者不得接种。

注意事项

(1)启开安瓿(或小瓶)和注射时, 切勿使消毒剂接触疫苗。(2)安瓿有裂纹、标签不清或溶解后不清晰者均可使用。(3)安瓶开封后,疫苗应在1小时内用完。(4)注射过免疫球蛋白者,应间隔1个月以后方可接种本疫苗。

贮藏

于2~8℃以下避光保存和运输。

规格

复溶后每瓶2.0ml。每1次人用剂量0.5ml,含麻疹活病毒应不低于3.01gCCID50。

证据Evidence

  • 批准文号: 国药准字S20063038
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.